Perrigo Company plc Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Perrigo Company plc share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2018-12-31 was -184.00K shares.
- Perrigo Company plc share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2018-09-29 was 90.00K shares, a 9.82% decline year-over-year.
- Perrigo Company plc share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2018-06-30 was 74.00K shares, a 131.97% increase year-over-year.
- Perrigo Company plc share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2018-03-31 was 53.00K shares, a 268.06% increase year-over-year.
- Perrigo Company plc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 0.00 shares, a 100.00% decline from fiscal 2019.
- Perrigo Company plc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2019 was 27.00K shares, a 18.18% decline from fiscal 2018.
- Perrigo Company plc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2018 was 33.00K shares, a 6.45% increase from fiscal 2017.
- Perrigo Company plc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2017 was 31.00K shares, a 74.59% decline from fiscal 2016.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2020-12-31 | 0.00 shares 10-K · filed 2021-03-01 | |
| 2019-12-31 | 27.00K shares 10-K · filed 2021-03-01 | |
| 2018-12-31 | -184.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | 33.00K shares 10-K · filed 2020-02-27 |
| 2018-09-29 | 90.00K shares 10-Q · filed 2018-11-08 | 101.90K shares derived: sum of 4 quarters · filed 2019-02-27 |
| 2018-06-30 | 74.00K shares 10-Q · filed 2018-08-09 | 111.70K shares derived: sum of 4 quarters · filed 2019-02-27 |
| 2018-03-31 | 53.00K shares 10-Q · filed 2018-05-08 | 69.60K shares derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-12-31 | -115.10K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | 31.00K shares 10-K · filed 2019-02-27 |
| 2017-09-30 | 99.80K shares 10-Q · filed 2018-11-08 | -14.90K shares derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-07-01 | 31.90K shares 10-Q · filed 2018-08-09 | 70.30K shares derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-04-01 | 14.40K shares 10-Q · filed 2018-05-08 | 57.40K shares derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | -161.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | 122.00K shares 10-K · filed 2018-03-01 |
| 2016-10-01 | 185.00K shares 10-Q · filed 2017-11-09 | 201.00K shares derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-07-02 | 19.00K shares 10-Q · filed 2017-08-10 | 170.00K shares derived: sum of 4 quarters · filed 2017-08-10 |
| 2016-04-02 | 79.00K shares 10-Q · filed 2017-05-30 | 208.00K shares derived: sum of 4 quarters · filed 2017-05-30 |
| 2015-12-31 | -82.00K shares derived: 10-K 6 month − 10-Q/A 3 month · filed 2017-05-22 | 164.00K shares derived: sum of 4 quarters · filed 2017-05-23 |
| 2015-09-26 | 154.00K shares 10-Q/A · filed 2017-05-23 | 286.00K shares derived: sum of 4 quarters · filed 2017-05-23 |
| 2015-06-27 | 57.00K shares 10-Q/A · filed 2017-05-22 | 170.00K shares 10-KT · filed 2016-02-25 |
| 2015-03-28 | 35.00K shares 10-Q/A · filed 2017-05-22 | 87.00K shares derived: sum of 4 quarters · filed 2017-05-22 |
| 2014-12-27 | 40.00K shares 10-Q · filed 2015-02-05 | 92.00K shares derived: sum of 4 quarters · filed 2015-11-02 |
| 2014-09-27 | 186.00K shares 10-Q · filed 2015-11-02 | 122.00K shares derived: sum of 4 quarters · filed 2015-11-02 |
| 2014-06-28 | -174.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-14 | 200.00K shares 10-K · filed 2014-08-14 |
| 2014-03-29 | 40.00K shares 10-Q · filed 2015-04-29 | |
| 2013-12-28 | 70.00K shares 10-Q · filed 2015-02-05 | |
| 2013-09-28 | 264.00K shares 8-K · filed 2014-11-20 | |
| 2013-03-30 | 43.00K shares 10-Q · filed 2014-05-07 | |
| 2012-12-29 | 138.00K shares 10-Q · filed 2014-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |